Adverse outcome pathways: Application to enhance mechanistic understanding of neurotoxicity.
about
Development of the Adverse Outcome Pathway (AOP): Chronic binding of antagonist to N-methyl-d-aspartate receptors (NMDARs) during brain development induces impairment of learning and memory abilities of children.Strategies to improve the regulatory assessment of developmental neurotoxicity (DNT) using in vitro methods.
P2860
Adverse outcome pathways: Application to enhance mechanistic understanding of neurotoxicity.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Adverse outcome pathways: Appl ...... nderstanding of neurotoxicity.
@en
Adverse outcome pathways: Appl ...... nderstanding of neurotoxicity.
@nl
type
label
Adverse outcome pathways: Appl ...... nderstanding of neurotoxicity.
@en
Adverse outcome pathways: Appl ...... nderstanding of neurotoxicity.
@nl
prefLabel
Adverse outcome pathways: Appl ...... nderstanding of neurotoxicity.
@en
Adverse outcome pathways: Appl ...... nderstanding of neurotoxicity.
@nl
P2860
P921
P1476
Adverse outcome pathways: Appl ...... nderstanding of neurotoxicity.
@en
P2093
Anna Bal-Price
M E Bette Meek
P2860
P356
10.1016/J.PHARMTHERA.2017.05.006
P5008
P577
2017-05-18T00:00:00Z
2017-11-01T00:00:00Z